• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

公众对 COVID-19 疫苗有效性和效力下降的误解:来自爱尔兰的实验证据。

Public misperceptions of COVID-19 vaccine effectiveness and waning: experimental evidence from Ireland.

机构信息

Economic and Social Research Institute & Department of Economics, Trinity College Dublin, Ireland, ESRI, Whitaker Square, Sir John Rogerson's Quay, Dublin 2, Ireland.

Economic and Social Research Institute & Department of Psychology, Trinity College Dublin, Ireland.

出版信息

Public Health. 2023 Jan;214:81-84. doi: 10.1016/j.puhe.2022.11.002. Epub 2022 Nov 11.

DOI:10.1016/j.puhe.2022.11.002
PMID:36521276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9650565/
Abstract

OBJECTIVES

The study set out to measure public understanding of COVID-19 vaccine effectiveness (VE) and how effectiveness wanes with time since vaccination. Because perceived VE is a strong predictor of vaccine uptake, measuring perceptions can inform public health policy and communications.

STUDY DESIGN

Online randomised experiment.

METHODS

The study was undertaken in Ireland, which has high vaccination rates. A nationally representative sample (n = 2000) responded to a scenario designed to measure perceptions of COVID-19 VE against mortality. The length of time since vaccination in the scenario was randomly varied across four treatment arms (2 weeks, 3 months, 6 months, and 9 months).

RESULTS

The public underestimates VE, with substantial variation in perceptions. A majority (57%) gave responses implying perceived VE against mortality of 0-85%, i.e., below scientific estimates. Among this group, mean perceived VE was just 49%. Over a quarter (26%) gave responses implying perceived VE greater than 95%, i.e., above scientific estimates. Comparing the four treatment groups, responses took no account of vaccine waning. Perceived VE was actually higher 9 months after vaccination than 2 weeks after vaccination.

CONCLUSION

Despite high vaccination rates, most of the public in Ireland underestimates VE. Furthermore, the general public has not absorbed the concept of vaccine waning in the months following vaccination. Both misperceptions may reduce vaccine uptake, unless public health authorities act to correct them through improved communication.

摘要

目的

本研究旨在衡量公众对 COVID-19 疫苗有效性(VE)的理解,以及疫苗接种后随着时间推移有效性如何下降。因为感知的 VE 是疫苗接种率的一个强有力的预测指标,所以衡量这些认知可以为公共卫生政策和沟通提供信息。

设计

在线随机实验。

方法

该研究在爱尔兰进行,爱尔兰的疫苗接种率很高。一个具有全国代表性的样本(n=2000)对一个旨在衡量对 COVID-19 VE 对死亡率的感知的情景做出了回应。情景中疫苗接种后的时间长度在四个处理组(2 周、3 个月、6 个月和 9 个月)中随机变化。

结果

公众低估了 VE,对 VE 的认知存在很大差异。大多数(57%)的人给出的回应表明,对死亡率的感知 VE 在 0-85%之间,即低于科学估计。在这群人中,平均感知 VE 仅为 49%。超过四分之一(26%)的人给出的回应表明,对 VE 的感知大于 95%,即高于科学估计。比较四个处理组,人们的回应没有考虑到疫苗衰减。实际上,在接种疫苗 9 个月后,感知 VE 高于接种疫苗 2 周后。

结论

尽管疫苗接种率很高,但爱尔兰的大多数公众仍然低估了 VE。此外,公众普遍没有吸收疫苗接种后几个月内疫苗衰减的概念。这两种误解都可能降低疫苗接种率,除非公共卫生当局通过改善沟通来纠正这些误解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b12/9650565/14e8a2b9070d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b12/9650565/6eb946a2f71c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b12/9650565/14e8a2b9070d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b12/9650565/6eb946a2f71c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b12/9650565/14e8a2b9070d/gr2_lrg.jpg

相似文献

1
Public misperceptions of COVID-19 vaccine effectiveness and waning: experimental evidence from Ireland.公众对 COVID-19 疫苗有效性和效力下降的误解:来自爱尔兰的实验证据。
Public Health. 2023 Jan;214:81-84. doi: 10.1016/j.puhe.2022.11.002. Epub 2022 Nov 11.
2
A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.一种用于 COVID-19 疫苗效力衰减和增强的对数几率系统。
Vaccine. 2022 Jun 21;40(28):3821-3824. doi: 10.1016/j.vaccine.2022.05.039. Epub 2022 May 20.
3
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
4
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged ≥65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021.COVID-19 疫苗对≥65 岁人群中出现症状的 SARS-CoV-2 感染、COVID-19 相关住院和死亡的有效性:基于国家登记数据链接的 2021 年 2 月至 9 月的队列研究。
PLoS One. 2022 Sep 13;17(9):e0274008. doi: 10.1371/journal.pone.0274008. eCollection 2022.
5
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study.马来西亚对 BNT162b2 和科兴疫苗的 COVID-19 疫苗有效性下降:一项观察性研究。
Int J Infect Dis. 2022 Jun;119:69-76. doi: 10.1016/j.ijid.2022.03.028. Epub 2022 Mar 22.
6
The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK.爱尔兰和英国 COVID-19 疫苗犹豫和抵制的心理和行为相关性。
Acta Psychol (Amst). 2022 May;225:103550. doi: 10.1016/j.actpsy.2022.103550. Epub 2022 Feb 28.
7
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.在英国和美国,针对成年人的 COVID-19 疫苗副作用风险的描述和沟通对疫苗接种意愿的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Sep 6;22(1):592. doi: 10.1186/s13063-021-05484-2.
8
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性:一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
9
Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.2021 年 3 月至 10 月估计的 COVID-19 疫苗对 SARS-CoV-2 感染后血清转换的有效性。
Vaccine. 2023 Apr 6;41(15):2596-2604. doi: 10.1016/j.vaccine.2023.03.006. Epub 2023 Mar 9.
10
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.在德尔塔和奥密克戎变异株流行期间,mRNA 疫苗加强针在成年人中的 COVID-19 相关急诊和紧急护理就诊和住院方面的效果 - VISION 网络,10 个州,2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. doi: 10.15585/mmwr.mm7104e3.

引用本文的文献

1
Efficacy, safety, and public attitude toward COVID-19 vaccines: A systematic review.COVID-19 疫苗的疗效、安全性和公众态度:系统评价。
Ann Afr Med. 2023 Oct-Dec;22(4):405-414. doi: 10.4103/aam.aam_13_23.

本文引用的文献

1
Strengthened belief in vaccine effectiveness predicted increased COVID-19 vaccination intention and behaviour: Results from a nationally representative longitudinal survey of U.S. adults from July 2020 to April/May 2021.增强对疫苗有效性的信念预测会增加 COVID-19 疫苗接种意愿和行为:来自 2020 年 7 月至 2021 年 4/5 月期间对美国成年人进行的全国代表性纵向调查的结果。
Vaccine. 2022 Oct 6;40(42):6035-6041. doi: 10.1016/j.vaccine.2022.08.046. Epub 2022 Aug 26.
2
Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case-control study among US veterans.mRNA COVID-19 疫苗在一项美国退伍军人配对病例对照研究中对奥密克戎和德尔塔变异株的有效性。
BMJ Open. 2022 Aug 3;12(8):e063935. doi: 10.1136/bmjopen-2022-063935.
3
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records.第二剂接种后 6 个月以上 BNT162b2 和 ChAdOx1 新冠疫苗效力下降:使用电子健康记录链接的 OpenSAFELY 队列研究。
BMJ. 2022 Jul 20;378:e071249. doi: 10.1136/bmj-2022-071249.
4
SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis.SARS-CoV-2 疫苗对感染、有症状和重症 COVID-19 的有效性:系统评价和荟萃分析。
BMC Infect Dis. 2022 May 7;22(1):439. doi: 10.1186/s12879-022-07418-y.
5
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.第二剂 COVID-19 疫苗接种后 9 个月内的感染、住院和死亡风险:瑞典的一项回顾性、全人群队列研究。
Lancet. 2022 Feb 26;399(10327):814-823. doi: 10.1016/S0140-6736(22)00089-7. Epub 2022 Feb 4.
6
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina.北卡罗来纳州 9 个月期间的新冠疫苗有效性。
N Engl J Med. 2022 Mar 10;386(10):933-941. doi: 10.1056/NEJMoa2117128. Epub 2022 Jan 12.
7
BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.BNT162b2和ChAdOx1 nCoV-19疫苗对德尔塔变异株所致死亡的有效性
N Engl J Med. 2021 Dec 2;385(23):2195-2197. doi: 10.1056/NEJMc2113864. Epub 2021 Oct 20.
8
Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review.预测 COVID-19 疫苗接受、意愿和犹豫的因素:范围综述。
Front Public Health. 2021 Aug 13;9:698111. doi: 10.3389/fpubh.2021.698111. eCollection 2021.
9
A lack of perceived benefits and a gap in knowledge distinguish the vaccine hesitant from vaccine accepting during the COVID-19 pandemic.在新冠疫情期间,对疫苗益处的认知不足以及知识差距,使得对疫苗持犹豫态度者有别于接受疫苗者。
Psychol Med. 2023 May;53(7):3238-3241. doi: 10.1017/S0033291721003743. Epub 2021 Sep 2.
10
Efficacy information influences intention to take COVID-19 vaccine.有效性信息影响接种 COVID-19 疫苗的意愿。
Br J Health Psychol. 2022 May;27(2):300-319. doi: 10.1111/bjhp.12546. Epub 2021 Jul 11.